Previous studies have shown that the expression of Nrf2 and phosphorylated Nrf2 is elevated in pituitary adenomas [52], along with the downstream effector HO-1, indicating the activation of the Nrf2 signaling pathway and its potential role in the development of pituitary adenoma cells [53]. The gene discussed is HMOX1; the disease is pituitary gland adenoma.